Shlomo A. Koyfman

8.2k total citations · 1 hit paper
240 papers, 3.3k citations indexed

About

Shlomo A. Koyfman is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Shlomo A. Koyfman has authored 240 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Otorhinolaryngology, 88 papers in Surgery and 88 papers in Oncology. Recurrent topics in Shlomo A. Koyfman's work include Head and Neck Cancer Studies (129 papers), Nonmelanoma Skin Cancer Studies (58 papers) and Head and Neck Surgical Oncology (33 papers). Shlomo A. Koyfman is often cited by papers focused on Head and Neck Cancer Studies (129 papers), Nonmelanoma Skin Cancer Studies (58 papers) and Head and Neck Surgical Oncology (33 papers). Shlomo A. Koyfman collaborates with scholars based in United States, Australia and Spain. Shlomo A. Koyfman's co-authors include David J. Adelstein, C.A. Reddy, Brian B. Burkey, Matthew C. Ward, Joseph Scharpf, J.F. Greskovich, Sue S. Yom, Samuel T. Chao, John H. Suh and Allison T. Vidimos and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shlomo A. Koyfman

217 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline

2019 223 citations Shlomo A. Koyfman, Sue S. Yom et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shlomo A. Koyfman United States	28	1.3k	1.2k	1.1k	914	629	240	3.3k
Zain Husain United States	32	1.0k 0.8×	1.1k 0.9×	760 0.7×	1.0k 1.1×	337 0.5×	141	3.3k
A. Aupérin France	29	357 0.3×	839 0.7×	1.2k 1.1×	1.3k 1.4×	602 1.0×	77	3.2k
Pierluigi Bonomo Italy	26	688 0.5×	668 0.6×	864 0.8×	1.1k 1.2×	234 0.4×	172	2.7k
Brian B. Burkey United States	31	1.3k 1.0×	1.9k 1.5×	1.2k 1.0×	1.1k 1.2×	379 0.6×	185	3.9k
Thom R. Loree United States	38	1.2k 0.9×	2.1k 1.7×	1.1k 1.0×	661 0.7×	468 0.7×	85	4.5k
John Hay Canada	23	1.3k 0.9×	1.1k 0.9×	906 0.8×	948 1.0×	148 0.2×	58	2.4k
Allen M. Chen United States	38	2.2k 1.7×	1.9k 1.6×	1.3k 1.1×	1.3k 1.5×	192 0.3×	133	3.9k
Silke Tribius Germany	27	882 0.7×	861 0.7×	773 0.7×	490 0.5×	190 0.3×	83	2.1k
Mark Zafereo United States	41	1.2k 0.9×	1.8k 1.5×	1.6k 1.4×	942 1.0×	385 0.6×	192	4.9k
Kenneth S. Hu United States	25	1.0k 0.8×	1.0k 0.8×	987 0.9×	904 1.0×	161 0.3×	133	2.6k

Countries citing papers authored by Shlomo A. Koyfman

Since Specialization

Citations

This map shows the geographic impact of Shlomo A. Koyfman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shlomo A. Koyfman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shlomo A. Koyfman more than expected).

Fields of papers citing papers by Shlomo A. Koyfman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shlomo A. Koyfman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shlomo A. Koyfman. The network helps show where Shlomo A. Koyfman may publish in the future.

Co-authorship network of co-authors of Shlomo A. Koyfman

This figure shows the co-authorship network connecting the top 25 collaborators of Shlomo A. Koyfman. A scholar is included among the top collaborators of Shlomo A. Koyfman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shlomo A. Koyfman. Shlomo A. Koyfman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Cong, J.L. Geiger, Tamara A. Sussman, et al.. (2024). Plasma circulating tumor DNA in patients with cutaneous squamous cell carcinoma: Initial experience.. Journal of Clinical Oncology. 42(16_suppl). e15034–e15034. 1 indexed citations

Wysong, Ashley, Ally‐Khan Somani, Sherrif F. Ibrahim, et al.. (2024). Incorporating the 40-Gene Expression Profile (40-GEP) Test within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors. SKIN The Journal of Cutaneous Medicine. 8(1). s334–s334. 1 indexed citations

Arron, Sarah T., Javier Cañueto, Jennifer J. Siegel, et al.. (2024). Association of a 40-Gene Expression Profile With Risk of Metastatic Disease Progression of Cutaneous Squamous Cell Carcinoma and Specification of Benefit of Adjuvant Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 120(3). 760–771. 5 indexed citations

Ladwa, Rahul, Ann W. Silk, Muhammad A. Khattak, et al.. (2024). 940TiP INTerpath-007: A phase II/III, adaptive, randomized study of neoadjuvant and adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) for treatment of resectable locally advanced (LA) cutaneous squamous cell carcinoma (cSCC). Annals of Oncology. 35. S652–S653. 4 indexed citations

Granger, Emily, Fadi Murad, Emily J. Anstadt, et al.. (2023). A multicenter real-world analysis of first-line systemic monotherapy for locally advanced basal cell carcinoma. JAAD Case Reports. 42. 69–71. 1 indexed citations

Yang, Kailin, Shauna R. Campbell, N.M. Woody, et al.. (2023). Comparison of real‐world outcomes following immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma with outcomes of randomized controlled trials. Head & Neck. 45(4). 862–871. 3 indexed citations

Hoda, Raza S., et al.. (2023). ERBB2 Amplification and HER2 Expression in Salivary Duct Carcinoma: Evaluation of Scoring Guidelines and Potential for Expanded Anti-HER2 Therapy. Modern Pathology. 36(10). 100273–100273. 9 indexed citations

Dima, Danai, Robert R. Lorenz, B. Prendes, et al.. (2023). Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement. Head & Neck. 45(8). 2149–2154. 3 indexed citations

Rabinowits, Guilherme, Michael R. Migden, Todd Schlesinger, et al.. (2021). Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma. SHILAP Revista de lepidopterología. 1(4). 100045–100045. 9 indexed citations

10.

Tsai, C. Jillian, Thomas J. Galloway, Danielle N. Margalit, et al.. (2020). Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary. Head & Neck. 43(1). 392–406. 21 indexed citations

11.

Broughman, James R., David D. Xiong, Benjamin J. Moeller, et al.. (2020). Rethinking the 10‐pack‐year rule for favorable human papillomavirus–associated oropharynx carcinoma: A multi‐institution analysis. Cancer. 126(12). 2784–2790. 10 indexed citations

12.

Sherman, Eric J., Jonathan Harris, Keith C. Bible, et al.. (2020). 1914MO Randomized phase II study of radiation therapy and paclitaxel with pazopanib or placebo: NRG-RTOG 0912. Annals of Oncology. 31. S1085–S1085. 4 indexed citations

13.

Ruiz, Emily S., Shlomo A. Koyfman, Syril Keena T. Que, Jason Kass, & Chrysalyne D. Schmults. (2019). Evaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic margins. Publisher. 1 indexed citations

14.

Ward, Matthew C., Joseph Scharpf, Eric Lamarre, et al.. (2019). Tumor Volume Useful Beyond Classic Criteria in Selecting Larynx Cancers For Preservation Therapy. The Laryngoscope. 130(10). 2372–2377. 6 indexed citations

15.

Koyfman, Shlomo A., Nikhil Joshi, Eric Lamarre, et al.. (2018). Validating the AJCC 8th Edition of the Oral Cavity Cancer Staging System: A Multi-institutional Collaborative Study. International Journal of Radiation Oncology*Biology*Physics. 102(3). S22–S22. 3 indexed citations

16.

Manyam, Bindu V., Adam Garsa, R Chin, et al.. (2016). A Multi-institutional Comparison of Outcomes of Immunocompromised and Immunocompetent Patients Treated With Surgery and Radiation Therapy for Cutaneous Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 94(4). 948–948. 1 indexed citations

17.

Manyam, Bindu V., I. Mallick, May Abdel–Wahab, et al.. (2015). The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy. Journal of Gastrointestinal Surgery. 19(9). 1676–1683. 12 indexed citations

18.

Koyfman, Shlomo A., Philip E. Agre, Lew Classen, et al.. (2013). Consent Form Heterogeneity in Cancer Trials: The Cooperative Group and Institutional Review Board Gap. JNCI Journal of the National Cancer Institute. 105(13). 947–953. 14 indexed citations

19.

Balagamwala, Ehsan H., T. Djemil, Shlomo A. Koyfman, et al.. (2011). 3D Composite Dose is Necessary to Assess Cumulative Spinal Cord Dose for Retreatment of Spinal Tumors with Stereotactic Body Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 81(2). S647–S647. 1 indexed citations

20.

Koyfman, Shlomo A., et al.. (2005). Adenoid cystic carcinoma of the cervix. Gynecologic Oncology. 99(2). 477–480. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact